SARS CoV 2 News and Research

RSS

Exploring a variant-adapted SARS-CoV-2 recombinant protein vaccine

Researchers assessed the immunogenicity of a variant-adapted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recombinant protein vaccine boosted with an AS03 adjuvant.

8 Dec 2022

Adult females exhibit impaired muscle and pulmonary function after COVID-19 recovery

In a new study, researchers examined muscle and pulmonary dysfunction during moderate exercise in adult females who recovered from coronavirus disease 2019 (COVID-19).

8 Dec 2022

Exploring COVID-19 vaccination prioritization strategies for primary and booster doses

Researchers evaluated the coronavirus disease 2019 (COVID-19) vaccine, prioritizing options for primary and booster doses.

8 Dec 2022

Study explores the risk of new-onset diabetes mellitus following SARS-CoV-2 infections

Researchers evaluated individuals who had SARS-CoV-2 infections and were diagnosed with diabetes mellitus within six months of the onset of COVID-19 to understand the temporal relationship between SARS-CoV-2 infections and diabetes mellitus.

8 Dec 2022

Booster COVID-19 mRNA vaccinations marginally increase the durability of neutralizing antibody responses

Researchers investigated the immunological mechanisms behind the decreasing efficacy of COVID-19 vaccines by evaluating the durability and magnitude of neutralizing antibodies and memory B and T cell responses to booster doses of mRNA COVID-19 vaccine.

8 Dec 2022

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant.

7 Dec 2022

Study identifies characteristics linked with higher likelihood of post COVID-19 condition diagnosis

Many studies have described a variety of long-term effects of COVID-19, with symptoms including fatigue and malaise, breathing difficulties, and cognitive problems, often referred to as post COVID-19 condition or long COVID.

7 Dec 2022

What was the SARS-CoV-2 seroprevalence among US adults during 2021 and 2022?

In a recent Morbidity and Mortality Weekly Report (MMWR), the United States Center for Disease Control and Prevention (U.S.-CDC) published the preliminary results of the National Health and Nutrition Examination Survey (NHANES) for August 2021–May 2022.

7 Dec 2022

Improved early detection and analysis of airborne pathogens with new liquid-coated air filters

Researchers from the University of Maine and University of Massachusetts Amherst have designed new liquid-coated air filters that allow for improved early detection and analysis of airborne bacteria and viruses, including the one that causes COVID-19.

7 Dec 2022

Researchers explore the correlation between the dynamic shedding pattern of SARS-CoV-2 and viral load

Researchers attempted to establish an association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load, indicating its ribonucleic acid (RNA) levels, and the presence of infectious virions.

7 Dec 2022

What is the prevalence of pulmonary tissue injury among hospitalized COVID-19 patients?

Researchers identified risk factors for and the prevalence of persistent pulmonary tissue alterations among hospitalized coronavirus disease 2019 (COVID-19) patients.

7 Dec 2022

Air pollution-triggered immune surveillance deficits in the lungs increase the risk of respiratory diseases with aging

Researchers highlighted the significance of air quality in preserving immune health over the human lifespan, especially lung-related immunity, owing to the lungs' continuous exposure to the environment.

7 Dec 2022

Understanding why respiratory infections are more common in the winter

Researchers investigate the role of extracellular vesicles in the innate nasal mucosal response to several respiratory viruses.

6 Dec 2022

Pre-existing SARS-CoV-2 antibodies may increase the breadth of mRNA vaccines, study suggests

Nearly three years into the pandemic, many of us now carry antibodies against the virus - due to an infection or two, a few doses of mRNA vaccine, or a round of monoclonal-antibody treatment.

6 Dec 2022

COVID-19 vaccination may cause temporary menstrual disturbances in adolescent girls

The Pfizer-BioNTech mRNA-based COVID-19 vaccine may increase the risk of menstrual disturbances in adolescent girls in their first cycle after vaccination.

6 Dec 2022

Machine learning analysis suggests that there are four sub-phenotypes of long COVID

Researchers identified PASC [post-acute sequelae of coronavirus disease 2019 (COVID-19)] sub-phenotypes depending on conditions diagnosed within 1 to 3 months of acute infection by SARS-CoV-2.

6 Dec 2022

Is remdesivir treatment associated with reduced risk of inpatient mortality among US patients hospitalized with COVID-19?

Researchers assessed the effect of remdesivir on inpatient COVID-19-associated mortality among individuals hospitalized with SARS-CoV-2 infections in an enormous dataset of US residents beyond clinical trial settings.

6 Dec 2022

Is course delivery model (entirely online vs mix of online and in-person classes) associated with college students’ mental health?

Researchers assessed the association between the model of course delivery and mental distress among students attending college in the United States.

6 Dec 2022

Co-infecting pathogens and the microbiome from SARS-CoV-2 positive and negative samples

Researchers evaluated co-infections in SARS-CoV-2-infected patients.

6 Dec 2022

Wearing glasses does not reduce risk of COVID-19

A new study determines the impact of wearing glasses on the risk of infection with SARS-CoV-2 and other respiratory viruses.

5 Dec 2022

SARS CoV 2 News and Research

Exploring a variant-adapted SARS-CoV-2 recombinant protein vaccine

Adult females exhibit impaired muscle and pulmonary function after COVID-19 recovery

Exploring COVID-19 vaccination prioritization strategies for primary and booster doses

Study explores the risk of new-onset diabetes mellitus following SARS-CoV-2 infections

Booster COVID-19 mRNA vaccinations marginally increase the durability of neutralizing antibody responses

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

Study identifies characteristics linked with higher likelihood of post COVID-19 condition diagnosis

What was the SARS-CoV-2 seroprevalence among US adults during 2021 and 2022?

Improved early detection and analysis of airborne pathogens with new liquid-coated air filters

Researchers explore the correlation between the dynamic shedding pattern of SARS-CoV-2 and viral load

What is the prevalence of pulmonary tissue injury among hospitalized COVID-19 patients?

Air pollution-triggered immune surveillance deficits in the lungs increase the risk of respiratory diseases with aging

Understanding why respiratory infections are more common in the winter

Pre-existing SARS-CoV-2 antibodies may increase the breadth of mRNA vaccines, study suggests

COVID-19 vaccination may cause temporary menstrual disturbances in adolescent girls

Machine learning analysis suggests that there are four sub-phenotypes of long COVID

Is remdesivir treatment associated with reduced risk of inpatient mortality among US patients hospitalized with COVID-19?

Is course delivery model (entirely online vs mix of online and in-person classes) associated with college students’ mental health?

Co-infecting pathogens and the microbiome from SARS-CoV-2 positive and negative samples

Wearing glasses does not reduce risk of COVID-19

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News